Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Kanniess, Z. Diamant, M. Lomax, M. Jain (Reinfeld, Germany; Lund, Sweden; Cambridge, United Kingdom). Effects of low- vs high-dose fluticasone/formoterol combination therapy on AMP challenge in asthmatic patients. Eur Respir J 2013; 42: Suppl. 57, 3645

Member's Comments

No comment yet.

Related content which might interest you: Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS) Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Exhaled nitric oxide and the therapeutic regimens in childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 LATE-BREAKING ABSTRACT: Extended NO analysis is useful to modify anti-inflammatory treatment in asthmatic children with intermediate FENO50 Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT) Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis Source: International Congress 2016 – Airway biomarkers Year: 2016 Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Effect of surfactant-BL on efficiency of inhaled nitric oxide therapy in cardiac surgery patients with ARDS Source: Eur Respir J 2005; 26: Suppl. 49, 90s Year: 2005 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 A cluster randomized trial comparing strict, partial, and FeNO-guided asthma control strategies in primary care Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Different patterns of exhaled NO response to acute bronchodilation in asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Source: Eur Respir J 2010; 35: 72-78 Year: 2010 Influence of fluticasone propionate on levels of exhaled nitric oxide in asthmatic children: a dose response study Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016